i disagree in that imo they (CEs) do have *huge problems*

New Post Public Reply Private Reply Replies (1) Message Board
4kids gandalf48 #33407
i disagree in that imo they (CEs) do have *huge problems* with PTOI
and to be clear *imo* NN's *self planned* glitch of a few years ago was
their *rolling part of their reset* to another CE

that said .. will colluding entities' make up what they *lose* on PTOI (with P2O's
ability to execute) by *working* other heavily targeted OTC stox .. to replace
what they *cant* reset on PTOI .. absolutely

imo PTOI never deserved a $7.00+ PPS .. but equally so PTOI didn't deserve
to be compressed to the sub 2c level either .. imo *true value* currently ..
(until first sale is consummated) is $1.00 to $1.50 (call it $1.25) on an existing
IO of 125M ..

if the 2nd sale follows
on the heels of the first sale (within 12 months) and other material events
noted by RH in the March 2016's Shareholder Update are implemented in
parallel to P2O's first *southern state* sale .. i am not sure CEs' will ever be
able to reset PTOI back as is their *imo* pattern re: cycles of money always
being worked

key there for P2O investors .. *imo* is the last orchestrated TAKE UP on PTOI
was Jan 2013 .. 3 years and almost 10 months .. ago

4 price points imo will reveal just how *few* CEs' are willing to play NN's *game*

10c/20c/35c .. then 1.50 to 1.65 .. factor in *many* originals have a CB (cost
basis) of 80c (approximately) .. and CEs' dilemma is very very real ~

they have to pull *enough* GTCs to work the *math* so they don't trigger threshold .. and at some point .. CEs/SROs will have to *factually report* data
vs making it up as they go along

if P2O's *timing alignment* comes from *awareness* specific to tactics and
strategies .. designed to maximize CEs' financial pain (which i am not saying
currently exists but could very easily with other aspects addressed) coupled
with specifics designed to retain P2O investors with their shares for cash divs
(imo a very real possibility with the 2nd *southern state's* execution of 30
processors) then i expect it will be very visible to all with interest

imo unlike most targeted OTC stox .. PTOI is unique in who holds what and
from when ..

so for example if material events are 8k'd by mgmt .. and the decision is made
by X P2O investor to *sell* a % of their shares (say 20 to 25 percent) but
*hold* for future the balance of 75 to 80 percent .. that actually works against
the CEs/SROs .. and makes the visible *reset UP* .. even more pronounced

US Equities (courtesy of the SEC) are a totally rigged game .. but that doesn't
mean folks can't make $$$ off of the *protected* CEs' efforts (cycles of money)
and clearly there will always be those SURVIVORS who by sheer luck and/or
mgmt's determination and tenacity .. make *some* CEs' pay the price

i know exactly what i'm looking for .. both with P2O's first sale and afterward

and i'm very clear that i'll be *trading* a % of my PTOI *shares .. phantom that
they may be* ... but holding a core for future *undertakings* out of P2O's *mgmt* .. provided my caveats continue to be met ..

4kids

Plastic2Oil, Inc. (PTOI) Stock Research Links

PTOI Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

DIRECTV Bags New NHL Deals: Stakes for Sports Fans

Updated Category News Views 209

NHL Fans, Strap in: DIRECTV Expands Its Lineup In a world where keeping up with your favorite team gets tougher each day, DIRECTV just lobbed a puck right into the net with their latest play. They've snagged a multi-year deal with the NHL for the Carolina Hurricanes, Columbus Blue Jackets, Minnesota Wild, and St. Louis Blues networks. It's a game changer, folks. If you...

Continue Reading
Survivors Secure $800M Settlement with NY Archdiocese

Updated Category News Views 137

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Continue Reading
Swanson Nexus Pro Launch: Boost for Dietitians

Updated Category News Views 160

Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...

Continue Reading
Millrose Faces Securities Fraud Suit Amidst Decline

Updated Category News Views 171

Dark Clouds Over Millrose Properties Holy smokes, folks, if Millrose Properties thought it could skirt under the radar, they were dead wrong. The curtain's been peeled back, and what do we see? A mess of securities fraud allegations and financial hiccups that’s driving its shareholders mad. October wasn’t too friendly—Hunterbrook Media dropped a bombshell revealing...

Continue Reading
Axon Body 5: A Leap Forward in AI for Public Safety

Updated Category News Views 251

Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...

Continue Reading
Honeywell Aerospace Faces Class Action: Deadline Looms

Updated Category News Views 93

Navigating the Legal Storm with Honeywell Look, investors never have it easy, and when lawsuits start flying like today's news about Honeywell Aerospace, you better have your wits about you. Now here comes Kahn Swick & Foti, LLC, ringing the alarm bells. Any holders of Honeywell Aerospace stocks between late June and early September of '26 are squarely in the spotlight....

Continue Reading
World Young Scientist Summit 2026 in Wenzhou Kicks Off

Updated Category News Views 98

Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...

Continue Reading
What to Expect: Your First Therapy Session Insights

Updated Category News Views 136

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

Continue Reading
Gildan Faces Lawsuit: Allegations of Deceptive Practices Shake Investors

Updated Category News Views 216

Gildan's Troubles Unveiled The financial jungle can be a pretty treacherous place, and Gildan Activewear Inc. (NYSE: GIL) just found out how fickle the market can be. An 18.7% nosedive in Gildan's stock price after a securities fraud class action came knocking—if that isn't enough to stir up a hornet’s nest among investors, I don’t know what is. The Catalyst:...

Continue Reading
Apalutamide Boosts Outlook for Prostate Cancer Treatment

Updated Category News Views 69

Fresh Findings on High-Risk Prostate Cancer Treatments In an industry that often feels like a game of chess, Johnson & Johnson's recent news unveils another one of their strategic moves with the announcement of breakthrough results from their Phase 3 PROTEUS substudy. Turns out, ERLEADA®, their apalutamide treatment, isn't just another pawn; it's a potential...

Continue Reading

Top 5 Most Recently Viewed Articles

Sonnet BioTherapeutics to Showcase Innovations in Immunotherapy

Updated Category News Views 116

Sonnet BioTherapeutics Advances in Immunotherapy Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN) is making significant strides in the field of oncology, thanks to its innovative approach to immunotherapeutic drug development. The company recently announced an exciting opportunity to present its research at an esteemed conference dedicated to cancer research. Exciting...

Continue Reading
Win $1,500 for a Transformative First-Class Flight Experience

Updated Category News Views 129

Transform Your Travel with Upgraded Points' Contest Upgraded Points presents an exciting opportunity for travelers to experience the luxury of first-class flying without the usual financial burden. With the newly launched contest, one lucky winner will be awarded $1,500 to upgrade their domestic round-trip flight to first class and share their journey. This contest is...

Continue Reading
Florida Cancer Specialists Expands Team with Dinesh Keerty, MD

Updated Category News Views 135

Florida Cancer Specialists Welcomes Dr. Dinesh Keerty Florida Cancer Specialists & Research Institute, known for its commitment to outstanding cancer care, is excited to introduce Dr. Dinesh Keerty, a seasoned medical oncologist and hematologist, to its expanding team. He will be serving patients at two prominent locations: one on Medical Center Drive and another on...

Continue Reading
Glen Burnie Bancorp Reports Q3 2024 Results with Insights

Updated Category News Views 87

Glen Burnie Bancorp Financial Performance Overview Glen Burnie Bancorp (NASDAQ: GLBZ) has recently shared its financial results for the third quarter of 2024, revealing a net income of $129,000, equating to $0.04 per share, which reflects a significant decline from the previous year's $551,000 or $0.19 per share. The income for the nine-month period ending September 30,...

Continue Reading
Fifth Third’s Newline™ Recognized as Top Embedded Finance Solution

Updated Category News Views 287

Newline™ by Fifth Third Receives Prestigious Award Newline™ by Fifth Third has recently been celebrated as the Best New Embedded Finance Platform at the Big Bank Theory Awards, organized by Tearsheet. This award showcases the innovation and leadership present in the financial technology sector, particularly highlighting how companies are transforming the banking...

Continue Reading